血清白蛋白融合技术是一种开发长效重组蛋白药物的新技术。
Albumin fusion technology was a novel technology utilized to develop long-acting biologics.
结论：建立的重组蛋白药物C末端测序联用方法应用于实际药物的检测具有很高的实用价值和学术意义。
Conclusions: the established C-terminal sequencing method of the recombinant protein was applied to the actual drugs testing, have high practical value and academic significance.
应用推荐